Neoadjuvant Treatment in Renal Cell Carcinoma: Transforming Challenges into Opportunities.

European urology ·Vol. 81 ·No. 6 ·2022-00-00 ·Pages 574-575

Marandino L, Raggi D, Necchi A, Capitanio U

Abstract

暂无摘要

MeSH Terms

Carcinoma, Renal Cell/drug therapy Combined Modality Therapy Humans Kidney Neoplasms/drug therapy Neoadjuvant Therapy

Authors & Affiliations

4 authors, click to expand affiliations / ORCID

Marandino Laura

Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy; Division of Experimental Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: laura.lmarandino@gmail.com.

Raggi Daniele

Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy; Division of Experimental Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.

Necchi Andrea

Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.

Capitanio Umberto

Division of Experimental Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy.

Article Info

Journal

European urology

Abbr.

Eur Urol

ISSN

1873-7560

DOI

10.1016/j.eururo.2022.02.013

laura.lmarandino@gmail.com

Published

2022-00-00

Epub

2022-00-02

Pages

574-575

Language

English

Region

Switzerland

NLM ID

7512719

Subset

Corrections

CommentOn

PMID: 35183395

External Links

PubMed source DOI: 10.1016/j.eururo.2022.02.013 View journal details

Analysis Services

Neoadjuvant Treatment in Renal Cell Carcinoma: Transforming Challenges into Opportunities.

Contact

WeChat Official Account